1 |
Mishra BB, Tiwari VK. 2011. Natural products: an evolving role in future drug discovery. Eur J Med Chem 46: 4769-4807.
DOI
ScienceOn
|
2 |
Yang CS, Wang X. 2010. Green tea and cancer prevention. Nutr Cancer 62: 931-937.
DOI
ScienceOn
|
3 |
Hill JM, Loeb E, MacLellan A, Hill NO, Khan A, King JJ. 1975. Clinical studies of platinum coordination compounds in the treatment of various malignant diseases. Cancer Chemother Rep 59: 647-659.
|
4 |
Gupta S, Hussain T, Mukhtar H. 2003. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cells cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410: 177-185.
DOI
ScienceOn
|
5 |
Singh M, Bhui K, Singh R, Shukla Y. 2013. Tea polyphenols enhance cisplatin chemosensitivity in cervical cancer cells via induction of apoptosis. Life Sci 93: 7-16.
DOI
ScienceOn
|
6 |
Luo T, Wang J, Yin Y, Hua H, Jing J, Sun X, Li M, Zhang Y, Jiang Y. 2010. (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Res 12: R8. doi: 10.1186/bcr2473.
DOI
ScienceOn
|
7 |
Jordan P, Carmo-Fonseca M. 2000. Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci 57:1229-1235.
DOI
ScienceOn
|
8 |
Hartmann JT, Lipp HP. 2003. Toxicity of platinum compounds. Expert Opin Pharmacother 4: 889-901.
DOI
ScienceOn
|
9 |
Shamseddine AI, Farhat FS. 2011. Platinum-based compounds for the treatment of metastatic breast cancer. Chemotherapy 57: 468-487.
DOI
ScienceOn
|
10 |
Fraser M, Chan SL, Chan SS, Fiscus RR, Tsang BK. 2006. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells. Oncogene 25: 2203-2212.
DOI
ScienceOn
|
11 |
Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H. 2003. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 22: 4851-4859.
DOI
ScienceOn
|
12 |
Fatima S, Arivarasu NA, Mahmood R. 2007. Vitamin C attenuates cisplatin-induced alterations in renal brush border membrane enzymes and phosphate transport. Hum Exp Toxicol 26: 419-426.
DOI
ScienceOn
|
13 |
Ateşşahín A, Ceríbaşi AO, Yuce A, Bulmus O, Cikim G. 2007. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats. Basic Clin Pharmacol Toxicol 100: 121-126.
|
14 |
El-Mowafy AM, Al-Gayyar MM, Salem HA, El-Mesery ME, Darweish MM. 2010. Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling. Phytomedicine 17: 1067-1075.
DOI
ScienceOn
|
15 |
Sancho-Martinez SM, Prieto-Garcia L, Prieto M, Lopez- Novoa JM, Lopez-Hernandez FJ. 2012. Subcellular targets of cisplatin cytotoxicity: an integrated view. Pharmacol Ther 136: 35-55.
DOI
ScienceOn
|
16 |
Bartelink H, Schellens JH, Verheij M. 2002. The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur J Cancer 38: 216-222.
DOI
ScienceOn
|
17 |
Matsuyama R, Reddy S, Smith TJ. 2006. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24: 3490-3496.
DOI
ScienceOn
|
18 |
Lonning PE. 2010. Molecular basis for therapy resistance. Mol Oncol 4: 284-300.
DOI
ScienceOn
|
19 |
Vogl DT, Stadtmauer EA. 2006. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed. Bone Marrow Transplant 37: 985-987.
DOI
ScienceOn
|
20 |
Shrubsole MJ, Lu W, Chen Z, Shu XO, Zheng Y, Dai Q, Cai Q, Gu K, Ruan ZX, Gao YT, Zheng W. 2009. Drinking green tea modestly reduces breast cancer risk. J Nutr 139:310-316.
|
21 |
Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. 2007. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 245: 232-241.
DOI
ScienceOn
|
22 |
Chan MM, Soprano KJ, Weinstein K, Fong D. 2006. Epigallocatechin- 3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J Cell Physiol 207: 389-396.
DOI
ScienceOn
|
23 |
Tenenhouse HS, Scriver CR, Vizel EJ. 1980. Alkaline phosphatase activity does not mediate phosphate transport in the renal-cortical brush-border membrane. Biochem J 190: 473-476.
|
24 |
Tate SS, Meister A. 1985. -Glutamyl transpeptidase from kidney. Methods Enzymol 113: 400-419.
DOI
|
25 |
Nessa MU, Beale P, Chan C, Yu JQ, Huq F. 2012. Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells. Anticancer Res 32: 53-59.
|
26 |
Periasamy VS, Alshatwi AA. 2013. Tea polyphenols modulate antioxidant redox system on cisplatin-induced reactive oxygen species generation in a human breast cancer cell. Basic Clin Pharmacol Toxicol 112: 374-384.
DOI
ScienceOn
|
27 |
Graham HN. 1992. Green tea composition, consumption, and polyphenol chemistry. Prev Med 21: 334-350.
DOI
ScienceOn
|
28 |
Yee MS, Blakley BW, Begleiter A, Leith M. 2008. Delayed sodium thiosulphate administration reduces cisplatin efficacy on mouse EMT6 tumour cells in vitro. J Otolaryngol Head Neck Surg 37: 638-641.
|
29 |
Khan SA, Priyamvada S, Khan W, Khan S, Farooq N, Yusufi AN. 2009. Studies on the protective effect of green tea against cisplatin induced nephrotoxicity. Pharmacol Res 60:382-391.
DOI
ScienceOn
|
30 |
Chuthapisith S, Eremin JM, El-Sheemy M, Eremin O. 2006. Neoadjuvant chemotherapy in women with large and locally advanced breast cancer: chemoresistance and prediction of response to drug therapy. Surgeon 4: 211-219.
DOI
ScienceOn
|
31 |
Sladowski D, Steer SJ, Clothier RH, Balls M. 1993. An improved MTT assay. J Immunol Methods 157: 203-207.
DOI
ScienceOn
|